Which of the following is a strong indicator of an Internet pharmacy’s compliance with state and federal laws and regulations and NABP's criteria?
a. DMEPOS
b. VAWD
c. PARE
d. VIPPS
e. PCOA
Answer: VIPPS. The VIPPS accreditation program (Verified Internet Pharmacy Practice Sites), is a strong indicator of an Internet pharmacy’s compliance with state and federal laws and regulations and NABP's criteria. Online retailers of prescription drugs who seek VIPPS accreditation know that they will benefit from NABP’s recognized credibility and the decade-old VIPPS program and Seal. The VIPPS Seal demonstrates public accountability – it is also a symbol of a pharmacy’s commitment to its patients’ health and safety.
DMEPOS: NABP's DMEPOS accreditation program is the reliable and cost-effective choice for those pharmacies seeking durable medical equipment, prosthetics, orthotics, and supplies accreditation. With more than 100 years of experience in pharmacy, NABP understands the complexities of modern pharmacy practice and is committed to ensuring that Medicare beneficiaries receive the appropriate products, services, and patient care associated with DMEPOS products.
VAWD, or Verified-Accredited Wholesale Distributors, is an accreditation for pharmaceutical wholesale distribution facilities. Those wholesale distributors that achieve accreditation are in compliance with state and federal laws and NABP's VAWD criteria and proudly display the VAWD Seal.
PCOA: Responding to the need expressed by the United States Department of Education, the Accreditation Council for Pharmacy Education (ACPE), and some US colleges and schools of pharmacy for an assessment tool to assist with curriculum development and review, NABP has worked closely with key stakeholders to develop the Pharmacy Curriculum Outcomes Assessment (PCOA).
PARE: The Pharmacist Assessment for Remediation Evaluation (PARE) is a multi-dimensional assessment that the boards of pharmacy may use as an auxiliary tool when making decisions regarding pharmacist practice deficiencies that are due to noncompliance with pharmacy practice standards, laws or regulations, and result in compromises to patient safety.